MAILI EXTREME 4x1 ml
MAILI EXTREME is a high-performance hyaluronic acid dermal filler developed by Sinclair Pharma (MaiLi) for significant volumization and deep structural enhancement.
Utilizing OxiFree™ cross-linking technology, it provides exceptional lift, projection, and longevity, making it ideal for restoring and redefining facial contours in areas requiring substantial support.
Product Overview
MAILI EXTREME is designed to create volume, lift, and structure in key facial areas such as the cheeks, jawline, and chin.
Its dense, highly elastic formulation offers the maximum lifting capacity within the MaiLi range, ensuring durable and natural-looking results that evolve harmoniously with facial movement.
Composition & Technology
Hyaluronic Acid: 25 mg/ml, non-animal origin monophasic HA with high purity for superior integration and durability.
Lidocaine: 3 mg/ml for increased patient comfort during injection.
OxiFree™ Technology: Exclusive cross-linking process preserving long HA chains, providing high elasticity and structural resilience with reduced free radicals.
Dynamic Spring Science: Allows the filler to adapt naturally to facial dynamics while maintaining volume and support for long-term rejuvenation.
Packaging
4 x 1 ml pre-filled syringes
Sterile needles included
Product labels and detailed instructions
Indications & Application Areas
Indications:
Deep facial volumization
Structural contouring and lift
Facial reshaping and rejuvenation
Application Areas:
Cheeks: Restores volume and projection
Jawline: Defines and enhances facial structure
Chin: Improves balance and proportion
Deep Folds: Corrects significant wrinkles and volume loss
Clinical Benefits
Powerful volumizing effect for facial lift and definition
High elasticity and projection for superior structural integrity
Long-lasting results with sustained lift and contour
Smooth tissue integration with natural expression
Comfortable treatment with integrated Lidocaine
Treatment Protocol
Administration: For use exclusively by qualified medical professionals.
Injection Depth: Deep dermis or subcutaneous layer, depending on indication.
Technique: Linear threading or bolus injection for volume restoration.
Maintenance: Recommended follow-up every 18–24 months depending on patient profile.
Manufacturer & Regulatory Information
Manufactured by: Sinclair Pharma (United Kingdom)
CE-marked Class III Medical Device under EU Regulation (MDR) 2017/745
ISO 13485 certified manufacturer
Distributed under compliance with AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) in Spain and the European Union
For Professional Use Only
As trusted distributors and providers of aesthetic medicine, Aesthisave® emphasizes that our products are strictly for professional use.
We insist that these treatments be administered only by trained and medically qualified personnel, ensuring the highest standards of safety, precision, and patient care.
